COVID-19 Vaccine Could Force US Dollar Crash, Warns CitiBank

The anticipated distribution of a coronavirus vaccine, coupled with additional monetary easing could spell big trouble for the US dollar come next year.

According to a Citibank research note, the US dollar could decline by as much as 20% in 2021 in the event of a successful mass vaccine distribution and further government stimulus measures. The latest Citibank forecast comes amid US-based Moderna announcing a 94.5% success rate of its COVID-19 experimental vaccine, and rival US-based Pfizer announcing a 90% efficacy rate for its vaccine.

German biotechnology company BioNTech has also created a coronavirus vaccine that appears to have a 90% success rate, while developers of Russia’s Sputnik V vaccine have also reported a 92% efficacy.

The US bank noted that the potential for the dollar crash is also dependent on the Federal Reserve’s ongoing economic support. If the central bank continues to utilize its wide array of financial tools to uphold the economy in 2021, in addition to keeping interest rates low even if inflation expectations rise, then the US yield curve could potentially steepen as well.


Information for this briefing was found via Citibank. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

First Majestic Sells Past Producing Del Toro Silver Mine For Up To US$60 Million

TomaGold Drills 6.68% Zinc Equivalent Over 48.05 Metres At Berrigan Mine Project

Related News

IATA: Global Passenger Traffic Plummeted 66% in 2020

Global air passenger levels suffered a dramatic drop in 2020, after numerous countries imposed tough...

Saturday, February 6, 2021, 11:40:00 AM

Revive Submits for IRB Approval; Expects to Enroll Patients in September

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial...

Wednesday, August 26, 2020, 10:07:43 AM

Zoltan Pozsar Says Dollar As Reserve Currency Is Under Assault

In his latest article, published with the Financial Times, Credit Suisse strategist Zoltan Pozsar reemphasized...

Saturday, January 21, 2023, 12:37:28 PM

Medicago, GSK Report 71% Efficacy Rate From Plant-Based COVID-19 Vaccine Study

Quebec-based biopharmaceutical firm Medicago and healthcare conglomerate GlaxoSmithKline (NYSE: GSK) announce today the results from...

Tuesday, December 7, 2021, 11:21:00 AM

Well Health Begins Offering Direct To Consumer COVID-19 Antibody Tests In Ontario

Well Health Technologies (TSX: WELL) is getting on the COVID-19 testing trend. The company this...

Thursday, December 3, 2020, 08:17:28 AM